Omada Health, Inc. director and officer Sean Duffy filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 12,944 shares of common stock acquired through the exercise of stock options on the same date.
Key Highlights
- Proposed sale: Sean Duffy, a director and officer of Omada Health, Inc., proposes to sell 12,944 shares of common stock with an aggregate market value of $240,499.52.
- Acquisition method: The 12,944 shares were acquired on November 4, 2026, through the exercise of stock options granted by the issuer, with payment made in cash.
- Exchange and broker: The proposed sale is to take place on NASDAQ, with Morgan Stanley Smith Barney LLC Executive Financial Services named as the broker.
- Shares outstanding: The filing states 61,216,703 shares of common stock were outstanding at the time of the notice.
- 10b5-1 plan: The filing indicates reliance on a Rule 10b5-1 plan adopted on March 13, 2026.
- Recent sales: The filing discloses seven prior 10b5-1 sales by Duffy in the preceding three months, totaling 75,360 shares with combined gross proceeds of $1,703,158.60.
Omada Health Officer Sean Duffy Proposes November 2026 Stock Sale Under 10b5-1 Plan
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 4, 2026, Sean Duffy, identified as both a director and officer of Omada Health, Inc. (NASDAQ:OMDA), proposes to sell 12,944 shares of common stock. The filing states the shares were acquired on November 4, 2026, through the exercise of stock options issued by the company, with the purchase price paid in cash. The aggregate market value of the shares to be sold is listed as $240,499.52.
The proposed sale is to be executed on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The approximate date of sale listed in the filing is November 4, 2026. The filing notes that Duffy is relying on a Rule 10b5-1 trading plan with an adoption date of March 13, 2026.
The filing also discloses seven sales of Omada Health common stock made by Duffy under 10b5-1 plans during the three months preceding this notice. Those transactions occurred on August 7, August 10, September 1, September 1, September 10, October 1, and October 1, 2026, involving share amounts of 8,628; 12,942; 12,944; 8,628; 14,960; 12,944; and 4,314 shares, respectively, with individual gross proceeds ranging from $90,162.60 to $327,197.07. The company's address is listed as 611 Gateway Blvd, Suite 120, South San Francisco, California 94080.
What Was Disclosed
Omada Health director and officer Sean Duffy filed a Form 144 on November 4, 2026, proposing to sell 12,944 shares of common stock acquired via stock option exercise, under a 10b5-1 plan adopted March 13, 2026, with an aggregate market value of $240,499.52.



Please wait processing your request...